… Combination antiretroviral therapy dramatically suppresses viral replication and reduces the
plasma HIV-1 viral load (vLoad) to below the limits of detection of the most sensitive clinical …

… ) 052 trial showed that antiretroviral therapy (ART) prevented … by human immunodeficiency
virus type 1 (HIV-1) in serodiscordant couples. ART was then offered to all patients with HIV-1 …

… HIV-1 RNA is durably suppressed by antiretroviral therapy, in patients with incomplete
suppression of plasma HIV-1 … to weeks after the start of antiretroviral therapy, is briefly described. …

… antiretroviral therapies both in our lab and clinic. In 1985–1986, we helped define an orally
… therapeutic range for AZT, thereby providing the first proof that effective inhibition of HIV-1 …

… of antiretroviral therapy reliably prevents HIV-1 transmission … early antiretroviral therapy had
a clinical benefit for both HIV-1… These results support the use of antiretroviral treatment as a …

Highly active antiretroviral therapy (HAART) 1 , 2 , 3 has dramatically decreased mortality
from HIV-1 infection 4 and is a major achievement of modern medicine. However, there is no …

… the emergence of HIV-1 drug resistance was central to the development of successful ARV
therapy (ART). Nonetheless, the acquisition and transmission of HIV-1 drug resistance loom …

… Human immunodeficiency virus type 1 (HIV-1) infection is characterized by a … antiretroviral
therapy (ART). To test this hypothesis, we evaluated a large, well-characterized cohort of HIV-1…

… Antiretroviral therapy (ART) is indicated during tuberculosis treatment in patients infected
with human immunodeficiency virus type 1 (HIV-1), but the timing for the initiation of ART when …

… Superior adherence to HIV-1 antiretroviral therapy is a mainstay of successful HIV management.
Studies performed in the early era of highly active antiretroviral therapy demonstrated …